The global Blood Collection Market is expanding as healthcare providers perform more diagnostic tests, chronic disease assessments, surgical procedures, and blood transfusions. Blood collection products are essential to clinical laboratories, hospitals, diagnostic centers, and blood banks because they support the safe collection and handling of specimens. These products include needles, tubes, lancets, collection sets, vacuum systems, and other devices used in clinical and diagnostic settings.

According to Fortune Business Insights, the global Blood Collection Market was valued at USD 5.09 billion in 2025. The market is projected to grow from USD 5.42 billion in 2026 to USD 8.92 billion by 2034, exhibiting a CAGR of 6.43% during the forecast period.

Factors Driving Blood Collection Market Growth

Increasing demand for diagnostic testing is a major driver of market growth. Blood samples are used to assess a wide range of health conditions, monitor ongoing treatments, and support routine health screening. As healthcare systems emphasize early detection and preventive care, the need for reliable blood collection products continues to rise.

The growing prevalence of chronic diseases also contributes to demand. Conditions requiring repeated laboratory monitoring increase the frequency of blood collection procedures. Hospitals and diagnostic laboratories need products that help preserve sample integrity and support efficient workflows.

Patient safety and infection prevention are additional priorities. Healthcare providers increasingly use safety-engineered needles, closed collection systems, and standardized specimen-handling procedures to reduce occupational exposure and contamination risks. Expansion of healthcare infrastructure and diagnostic services in developing economies is creating further opportunities for manufacturers.

Key Applications of Blood Collection Products

Diagnostics is a major application of blood collection products. Blood specimens are used for hematology, clinical chemistry, infectious disease testing, molecular diagnostics, and other laboratory investigations. Collection devices must be appropriate for the intended test and support proper sample handling.

Blood collection is also important for treatment-related procedures, including transfusion services and monitoring patients receiving medical therapies. Blood banks depend on suitable collection equipment, storage systems, and processes to support safe blood donation and component preparation.

Hospitals, diagnostic laboratories, clinics, and blood banks are major end users. Home-based testing and decentralized diagnostic services may also create opportunities for collection products designed for specific patient and care settings.

For more market insights, visit the report:

https://www.fortunebusinessinsights.com/blood-collection-market-116416

Emerging Trends in the Blood Collection Market

A significant trend is the increased adoption of safety-engineered devices. Needle-protection mechanisms and closed collection systems can help healthcare workers reduce exposure to bloodborne hazards when used correctly and alongside established safety procedures.

Automation is also influencing the market. Healthcare providers and laboratories are seeking ways to improve specimen identification, reduce manual handling, and streamline collection workflows. Barcode-based tracking and integrated laboratory systems can help maintain traceability from collection through testing.

Another development is the growing interest in less invasive and patient-friendly collection methods. These approaches may improve convenience in selected applications, although their suitability depends on the test, specimen requirements, and clinical setting. Manufacturers are also focusing on consistent product quality, ease of use, and compatibility with laboratory workflows.

Market Segmentation Analysis

By collection site, the market includes venous and capillary collection. Venous blood collection is the leading segment, accounting for approximately 74% of the market. It is widely used in hospitals, diagnostic laboratories, and blood banks because it can provide samples suitable for a broad range of laboratory tests.

Capillary collection is used in selected applications where smaller sample volumes are appropriate. It can be useful in certain point-of-care and screening settings, depending on the test requirements and patient circumstances.

By application, the market is divided into diagnostics and treatment. Diagnostics supports routine testing and disease monitoring, while treatment-related collection serves transfusion and other clinical requirements.

By method, products are categorized into manual and automated approaches. Manual collection remains common across healthcare settings, while automation is gaining attention where it can improve workflow efficiency and consistency. By end use, hospitals and blood banks are important customers, alongside diagnostic laboratories, clinics, and other healthcare facilities.

Regional Analysis

North America accounted for approximately 39% of the global market, supported by established healthcare infrastructure, high diagnostic testing volumes, and demand for safety-focused medical devices. The U.S. is an important market for blood collection tubes, needles, and advanced collection systems.

Europe represented approximately 28% of the market. Demand is supported by hospital services, clinical laboratories, blood donation programs, and established medical-device supply chains. Product quality and compliance with applicable medical-device requirements remain important considerations.

Asia Pacific accounted for approximately 25% of the market. Expanding healthcare infrastructure, growing access to diagnostic testing, and rising awareness of preventive health support demand across the region. Latin America and the Middle East and Africa provide further opportunities as laboratory networks, hospitals, and blood donation services expand.

Request Sample Report

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/blood-collection-market-116416

Competitive Landscape

Key companies operating in the blood collection market include Abbott, NIPRO Medical Corporation, BD, Terumo Corporation, Medtronic, QIAGEN, FL Medical s.r.l., Greiner AG, Haemonetics Corporation, F. Hoffmann-La Roche Ltd., Sarstedt AG & Co. KG, and SEKISUI CHEMICAL CO., LTD.

Companies compete on product reliability, safety features, quality control, pricing, manufacturing capacity, and distribution. Manufacturers are also working to improve collection systems and specimen-handling solutions to meet the needs of hospitals, laboratories, and blood banks.

Future Outlook

The blood collection market is expected to expand as diagnostic testing, chronic disease monitoring, blood donation services, and healthcare access continue to grow. Demand for safety-engineered devices, efficient collection workflows, and reliable specimen management is likely to support further product development. The market is projected to grow from USD 5.42 billion in 2026 to USD 8.92 billion by 2034, at a CAGR of 6.43%.

Explore Japan’s Market Opportunities  blood collection market Latest Insights